Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 4, 2002

View Archived Issues

New dosage form of Atrix's Leuprogel licensed in by Sanofi-Synthelabo

InKine submits chemistry supplement for new formulation of Visicol for colon cleansing

SpectRx acquires Sterling Medivations

Unexpected gene regulatory effects by probucol and BO-653

Pharmacia granted rights to foam delivery technology for use with Rogaine

Phase IIb clinical trial of NBI-6024 in diabetes set to commence

Pretarget product candidates in phase Ia clinical trials

MAP acquires European rights for Dopascan Injection for Parkinson's disease imaging

Genzyme Genetics acquires diagnostic cancer rights from Genzyme Molecular Oncology

Uridine derivatives with antibiotic properties reported by Aventis

Chugai researchers design vitamin D3 analogues with antipsoriatic activity

Aventis discloses novel vitronectin receptor antagonists

Kyowa Hakko and Lilly report new potent antitumor compounds

Suntory presents new compounds for the treatment of osteoporosis and other bone diseases

Scientists at Sumitomo identify novel PARP inhibitors

Novel betacin antibiotic described by Versicor

SCAP ligands: a promising new class of hypolipidemic drugs

Peptidomimetic exhibits broad antimicrobial and endotoxin-neutralizing activity

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...